A carregar...

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C

Hepatitis C virus (HCV) is estimated to affect up to 150 million people worldwide. Despite worldwide prevalence, treatment modalities prior to 2011 remained suboptimal, with low virologic response rates and intolerable side effect profiles. Fortunately, the landscape of treatment for chronic hepatit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Hepatol
Main Authors: Bell, Allison M., Wagner, Jamie L., Barber, Katie E., Stover, Kayla R.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4925941/
https://ncbi.nlm.nih.gov/pubmed/27403342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3852126
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!